SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

pharmacology chemotherapy

» Start this Course
(Practice similar questions for free)
Question:

6-Thioguanine (6-TG) mechanism

Author: Suzuki



Answer:

, a purine analog, is primarily used in the treatment of acute nonlymphocytic leukemia in combination with daunorubicin and cytarabine. Like 6-MP, 6-TG is converted intracellularly to TGMP (also called 6-thioguanylic acid) by the enzyme HGPRT. TGMP is further converted to the di- and triphosphates, thioguanosine diphosphate and thioguanosine triphosphate, which then inhibit the biosynthesis of purines and also the phosphorylation of GMP to guanosine diphosphate. The nucleotide form of 6-TG is incorporated into DNA that leads to cell-cycle arrest.


0 / 5  (0 ratings)

1 answer(s) in total

Author

Suzuki
Suzuki